These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24421906)

  • 1. Variation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM].
    Figueira M; Moschioni M; De Angelis G; Barocchi M; Sabharwal V; Masignani V; Pelton SI
    PLoS One; 2014; 9(1):e83798. PubMed ID: 24421906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations.
    Moschioni M; De Angelis G; Harfouche C; Bizzarri E; Filippini S; Mori E; Mancuso G; Doro F; Barocchi MA; Ruggiero P; Masignani V
    Vaccine; 2012 Feb; 30(7):1349-56. PubMed ID: 22210141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Otitis media: the chinchilla model.
    Giebink GS
    Microb Drug Resist; 1999; 5(1):57-72. PubMed ID: 10332723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
    Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
    Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence of Streptococcus pneumoniae serotype 6C in experimental otitis media.
    Sabharwal V; Figueira M; Pelton SI; Pettigrew MM
    Microbes Infect; 2012 Aug; 14(9):712-8. PubMed ID: 22414497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complement in host defense against pneumococcal otitis media.
    Sabharwal V; Ram S; Figueira M; Park IH; Pelton SI
    Infect Immun; 2009 Mar; 77(3):1121-7. PubMed ID: 19139190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.
    Shaffer TL; Balder R; Buskirk SW; Hogan RJ; Lafontaine ER
    PLoS One; 2013; 8(7):e67881. PubMed ID: 23844117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media.
    Marom T; Avraham E; Cinamon U; Tamir SO
    J Microbiol Immunol Infect; 2017 Oct; 50(5):714-717. PubMed ID: 26507672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
    Xu Q; Pryharski K; Pichichero ME
    Vaccine; 2017 Jan; 35(2):337-344. PubMed ID: 27919628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies.
    Harfouche C; Filippini S; Gianfaldoni C; Ruggiero P; Moschioni M; Maccari S; Pancotto L; Arcidiacono L; Galletti B; Censini S; Mori E; Giuliani M; Facciotti C; Cartocci E; Savino S; Doro F; Pallaoro M; Nocadello S; Mancuso G; Haston M; Goldblatt D; Barocchi MA; Pizza M; Rappuoli R; Masignani V
    Infect Immun; 2012 Jan; 80(1):451-60. PubMed ID: 22083702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide.
    Giebink GS; Berzins IK; Schiffman G; Quie PG
    J Infect Dis; 1979 Nov; 140(5):716-23. PubMed ID: 43345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis.
    Giebink GS
    Rev Infect Dis; 1981; 3(2):342-53. PubMed ID: 7256090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Otitis-prone Children Have Immunologic Deficiencies in Naturally Acquired Nasopharyngeal Mucosal Antibody Response after Streptococcus pneumoniae Colonization.
    Xu Q; Casey JR; Newman E; Pichichero ME
    Pediatr Infect Dis J; 2016 Jan; 35(1):54-60. PubMed ID: 26448450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal PspA and PspC proteins: potential vaccine candidates for experimental otitis media.
    Schachern PA; Tsuprun V; Ferrieri P; Briles DE; Goetz S; Cureoglu S; Paparella MM; Juhn S
    Int J Pediatr Otorhinolaryngol; 2014 Sep; 78(9):1517-21. PubMed ID: 25015773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization.
    Keller LE; Luo X; Thornton JA; Seo KS; Moon BY; Robinson DA; McDaniel LS
    Clin Vaccine Immunol; 2015 Nov; 22(11):1146-53. PubMed ID: 26311246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media.
    Wiertsema SP; Corscadden KJ; Mowe EN; Zhang G; Vijayasekaran S; Coates HL; Mitchell TJ; Thomas WR; Richmond PC; Kirkham LA
    PLoS One; 2012; 7(11):e49061. PubMed ID: 23152850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
    Figueira M; Fernandes P; Pelton SI
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
    Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Virulence of an Encapsulated Streptococcus pneumoniae Upon Expression of Pneumococcal Surface Protein K.
    Pipkins HR; Bradshaw JL; Keller LE; McDaniel LS
    J Infect Dis; 2018 Apr; 217(10):1637-1644. PubMed ID: 29394357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.